Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

As China embraces AI, only 24% of US pharma execs bet on it for drug-making

Summary by BizToc
Pharmaceutical companies have embraced artificial intelligence in drug research almost universally, yet few company executives expect AI to actually make drugs succeed, according to a Citi survey released on Tuesday. “The biggest risk to the AI-powered drug discovery thesis is not that AI fails to…

2 Articles

South China Morning PostSouth China Morning Post
Reposted by
BizTocBizToc
Center

As China embraces AI, only 24% of US pharma execs bet on it for drug-making

Study finds 50 companies had fully, partially or planned to scale AI, tech which could slash drug discovery costs by US$26 billion globally.

·Hong Kong, Hong Kong
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

South China Morning Post broke the news in Hong Kong, Hong Kong on Wednesday, September 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Artificial Intelligence icon

Artificial Intelligence

Pharma icon

Pharma

China icon

China

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal